Review finds more effective drugs to stop bleeding after childbirth

April 26, 2018, University of Birmingham
To reduce excessive bleeding at childbirth, the routine administration of a uterotonic drug called Oxytocin which contracts the uterus has become standard practice across the world. Credit: University of Birmingham

New evidence from a Cochrane review published today, led by a University of Birmingham scientist, suggests that alternative drugs may be more effective than the standard drug currently used to stop women bleeding after childbirth.

Bleeding after birth, also known as postpartum haemorrhage, is the most common reason why mothers die in worldwide. Although most healthy women can cope well with some bleeding at childbirth, others do not, and this can pose a serious risk to their health and even life.

To reduce excessive bleeding at childbirth, the routine administration of a uterotonic called Oxytocin which contracts the uterus has become standard practice across the world.

In this study, researchers from the Cochrane Pregnancy and Childbirth Group have reviewed the data of the births of 88,000 women who took part in 140 randomised trials, with the aim of identifying which uterotonics (including , as well as misoprostol, ergometrine, carbetocin or combinations of these) are most effective in preventing excessive bleeding after childbirth and have the least side-effects.

The Cochrane Review found that ergometrine plus oxytocin; misoprostol plus oxytocin; and carbetocin on its own, were more effective drugs for reducing excessive bleeding at childbirth rather than the current standard use of oxytocin on its own.

The team analysed all the available evidence to compare all of the drugs and calculated a ranking among them, providing robust effectiveness and side-effect profiles for each drug. Side-effects can include vomiting, and fever.

University of Birmingham Clinician Scientist Dr. Ioannis Gallos, of the Cochrane Pregnancy and Childbirth Group and Review Author, said: "Whilst death from is a rare complication, it is the most common reason why mothers die in childbirth worldwide and happens because a woman's womb has not contracted strongly enough after birth and results in excessive bleeding.

"Currently, to reduce excessive bleeding at childbirth, the standard practice across the world is to administer to women after childbirth a drug called oxytocin—a uterotonic which contracts the uterus and stimulates contractions to help push out the placenta.

"However, there are a number of other uterotonics and combinations of these drugs that can be given that may be more effective.

"By analysing data from 140 different clinical trials involving over 88,000 women, we have been able to use the evidence more efficiently to compare all of these drugs and calculate a ranking among them, providing robust effectiveness and side-effect profiles for each drug.

"Our research has highlighted which drugs may be more effective than oxytocin and we hope that this could impact existing recommendations and save mothers lives worldwide."

This Cochrane review is expected to be updated later this year to incorporate the results of some key ongoing studies which will report their findings in coming months, including a large study involving around 30,000 women across 10 different countries comparing the effectiveness of carbetocin versus oxytocin for preventing bleeding in women having a vaginal birth, and a UK-based trial involving more than 6,000 comparing carbetocin, oxytocin and ergometrine plus oxytocin combination.

Explore further: Labour–inducing drugs put to the test

More information: Ioannis D Gallos et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis, Cochrane Database of Systematic Reviews (2018). DOI: 10.1002/14651858.CD011689.pub2

Related Stories

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.

Simple treatment for severe bleeding could save lives of mothers around the world

April 26, 2017
An inexpensive and widely available drug could save the lives of one in three mothers who would otherwise bleed to death after childbirth, according to a major study published in The Lancet. The global trial of 20,000 women ...

New medicine to prevent mothers dying in childbirth succeeds in first trial in humans

March 21, 2017
The Monash University Institute of Pharmaceutical Sciences (MIPS) today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the ...

Childbirth deaths declining in U.S., new report finds

January 4, 2018
(HealthDay)—Improved management of excessive bleeding and high blood pressure during labor and delivery are helping to reduce the number of childbirth-related deaths in the United States, maternal health experts say.

Preventing postpartum hemorrhage

November 4, 2014
Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to trial results published ...

WHO revises childbirth guidelines to curb caesarean delivery surge

February 15, 2018
The UN health agency said Thursday it has revised a benchmark used by health professionals worldwide in caring for women during childbirth because it has caused a surge in interventions like caesarean sections that could ...

Recommended for you

Undiagnosed STIs can increase negative PMS symptoms

September 17, 2018
Women that have undiagnosed sexually transmitted infections may be at greater risk of experiencing negative premenstrual symptoms (PMS), according to new Oxford University research.

High dose folic acid does not prevent pre-eclampsia in high risk women

September 13, 2018
Taking high dose folic acid supplements in later pregnancy (beyond the first trimester) does not prevent pre-eclampsia in women at high risk for this condition, finds a randomised controlled trial published by The BMJ today.

Study finds air purifiers may benefit fetal growth

September 12, 2018
A new study led by SFU health sciences researchers Prabjit Barn and Ryan Allen reveals fetal growth may improve if pregnant women use portable air purifiers inside their homes.

Delayed childbearing is a growing source of multiple births, study shows

September 12, 2018
Starting in the 1980s, the number of multiple births—twins, triplets, quadruplets and quintuplets—steadily increased from about 20 sets per 1,000 live births to almost 35 sets per 1,000 live births in the 2010s.

Transforming pregnancy research with a smartphone app

September 5, 2018
For years, pregnant women have been underrepresented in biomedical research. Current treatments, interventions and guidelines do a poor job of taking into consideration the diverse characteristics of all pregnant women.

For women undergoing IVF, is fresh or frozen embryo transfer best?

August 21, 2018
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.